ILLUMINA INC (1ILMN.MI) Stock Price, Forecast & Analysis
BIT:1ILMN • US4523271090
1ILMN.MI Key Statistics, Chart & Performance
The current stock price of 1ILMN.MI is 104.44 EUR.
1ILMN.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1ILMN.MI.
1ILMN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1ILMN.MI. While 1ILMN.MI has a great health rating, its profitability is only average at the moment.
1ILMN.MI Financial Highlights
Over the last trailing twelve months 1ILMN.MI reported a non-GAAP Earnings per Share(EPS) of 3.74. The EPS increased by 152.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.39% | ||
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| Debt/Equity | 0.42 |
1ILMN.MI Forecast & Estimates
28 analysts have analysed 1ILMN.MI and the average price target is 97.42 EUR. This implies a price decrease of -6.72% is expected in the next year compared to the current price of 104.44.
For the next year, analysts expect an EPS growth of 93.48% and a revenue growth -1.07% for 1ILMN.MI
1ILMN.MI Ownership
1ILMN.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 38.18 | 17.297B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 32.78 | 17.028B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 32.77 | 17.018B | ||
| SRT | SARTORIUS AG | 30.28 | 13.718B | ||
| QIA | QIAGEN N.V. | 19.06 | 8.916B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 15 | 2.256B | ||
| EVT | EVOTEC SE | N/A | 2.197B | ||
| GXI | GERRESHEIMER AG | 6.63 | 687.001M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 15.24 | 236.042M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 161M |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1ILMN.MI
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA US
Employees: 9000
Phone: 18582024500
ILLUMINA INC / 1ILMN.MI FAQ
What does ILLUMINA INC do?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Can you provide the latest stock price for ILLUMINA INC?
The current stock price of 1ILMN.MI is 104.44 EUR. The price increased by 1.2% in the last trading session.
What is the dividend status of ILLUMINA INC?
1ILMN.MI does not pay a dividend.
What is the ChartMill rating of ILLUMINA INC stock?
1ILMN.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Would investing in ILLUMINA INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1ILMN.MI.
Can you provide the market cap for ILLUMINA INC?
ILLUMINA INC (1ILMN.MI) has a market capitalization of 16.05B EUR. This makes 1ILMN.MI a Large Cap stock.
Who owns ILLUMINA INC?
You can find the ownership structure of ILLUMINA INC (1ILMN.MI) on the Ownership tab.